Biogen Inc
Simbolis: 0R1B.L
LSE
220.98
USDRinkos kaina šiandien
27.5773
P/E santykis
0.4723
PEG koeficientas
32.12B
MRK kapitalizacija
- 0.00%
DIV pajamingumas
Biogen Inc (0R1B-L) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1049.9 | 4892.8 | 3802.5 | ||||||||||||
balance-sheet.row.short-term-investments | 0 | 0 | 1473.5 | 1541.1 | ||||||||||||
balance-sheet.row.net-receivables | 0 | 2100 | 2136.4 | 1961.7 | ||||||||||||
balance-sheet.row.inventory | 0 | 2527.4 | 1344.4 | 1351.5 | ||||||||||||
balance-sheet.row.other-current-assets | 0 | 1182 | 1417.6 | 740.8 | ||||||||||||
balance-sheet.row.total-current-assets | 0 | 6859.3 | 9791.2 | 7856.5 | ||||||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 3729.7 | 3702.5 | 3791.8 | ||||||||||||
balance-sheet.row.goodwill | 0 | 6219.2 | 5749 | 5761.1 | ||||||||||||
balance-sheet.row.intangible-assets | 0 | 0 | 1850.1 | 2221.3 | ||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 6219.2 | 7599.1 | 7982.4 | ||||||||||||
balance-sheet.row.long-term-investments | 0 | 460.7 | 1957.1 | 2602.2 | ||||||||||||
balance-sheet.row.tax-assets | 0 | 928.6 | 1226.4 | 1415.1 | ||||||||||||
balance-sheet.row.other-non-current-assets | 0 | 8647.3 | 277.8 | 229.3 | ||||||||||||
balance-sheet.row.total-non-current-assets | 0 | 19985.5 | 14762.9 | 16020.8 | ||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.total-assets | 0 | 26844.8 | 24554.1 | 23877.3 | ||||||||||||
balance-sheet.row.account-payables | 0 | 403.3 | 491.5 | 589.2 | ||||||||||||
balance-sheet.row.short-term-debt | 0 | 240.3 | 97.2 | 1088.2 | ||||||||||||
balance-sheet.row.tax-payables | 0 | 257.4 | 259.9 | 174.7 | ||||||||||||
balance-sheet.row.long-term-debt-total | 0 | 6788.2 | 6281 | 6274 | ||||||||||||
Deferred Revenue Non Current | 0 | 400 | 333 | 330.4 | ||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | ||||||||||||
balance-sheet.row.other-current-liab | 0 | 2533.3 | 2424.2 | 2446.1 | ||||||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8611.1 | 7892.9 | 8619.4 | ||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.capital-lease-obligations | 0 | 400 | 333 | 330.4 | ||||||||||||
balance-sheet.row.total-liab | 0 | 12045.4 | 11165.7 | 12917.6 | ||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||
balance-sheet.row.common-stock | 0 | 0.1 | 0.1 | 0.1 | ||||||||||||
balance-sheet.row.retained-earnings | 0 | 17627.6 | 16466.5 | 13911.7 | ||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | -153.7 | -164.9 | -106.7 | ||||||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -2674.6 | -2903.8 | -2908.9 | ||||||||||||
balance-sheet.row.total-stockholders-equity | 0 | 14799.4 | 13397.9 | 10896.2 | ||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 26844.8 | 24554.1 | 23877.3 | ||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | -9.5 | 63.5 | ||||||||||||
balance-sheet.row.total-equity | 0 | 14799.4 | 13388.4 | 10959.7 | ||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | ||||||||||||
Total Investments | 0 | 460.7 | 3430.6 | 4143.3 | ||||||||||||
balance-sheet.row.total-debt | 0 | 7428.5 | 6711.2 | 7692.6 | ||||||||||||
balance-sheet.row.net-debt | 0 | 6378.6 | 3291.9 | 5431.2 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 1161.1 | 3046.9 | 1556.1 | ||||||||||||
cash-flows.row.depreciation-and-amortization | 0 | 494.8 | 518.7 | 487.3 | ||||||||||||
cash-flows.row.deferred-income-tax | 0 | -305.8 | -168.6 | -426.8 | ||||||||||||
cash-flows.row.stock-based-compensation | 0 | -1063.8 | 264.3 | 250.8 | ||||||||||||
cash-flows.row.change-in-working-capital | 0 | -648.7 | -890.3 | -145.5 | ||||||||||||
cash-flows.row.account-receivables | 0 | 56.7 | -222.4 | 326 | ||||||||||||
cash-flows.row.inventory | 0 | -130.9 | -320.2 | -462.4 | ||||||||||||
cash-flows.row.account-payables | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-working-capital | 0 | -574.5 | -347.7 | -9.1 | ||||||||||||
cash-flows.row.other-non-cash-items | 0 | 1909.6 | -1386.7 | 1918 | ||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -7237.5 | -243.2 | -294.9 | ||||||||||||
cash-flows.row.acquisitions-net | 0 | 12.3 | 595 | 28.1 | ||||||||||||
cash-flows.row.purchases-of-investments | 0 | -5140.7 | -3448.5 | -3808.7 | ||||||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 8288.5 | 4661.3 | 3498.9 | ||||||||||||
cash-flows.row.other-investing-activites | 0 | -11.3 | 24.4 | 12.9 | ||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -4088.7 | 1589 | -563.7 | ||||||||||||
cash-flows.row.debt-repayment | 0 | -187.3 | -1002.2 | -170 | ||||||||||||
cash-flows.row.common-stock-issued | 0 | -44.3 | -1.9 | -0.7 | ||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | -750 | -1800 | ||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | ||||||||||||
cash-flows.row.other-financing-activites | 0 | -6 | -5.6 | -115.5 | ||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | 137 | -1759.7 | -2086.2 | ||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 35.1 | -55.7 | -59.8 | ||||||||||||
cash-flows.row.net-change-in-cash | 0 | -2369.4 | 1157.9 | 930.2 | ||||||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1049.9 | 3419.3 | 2261.4 | ||||||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 3419.3 | 2261.4 | 1331.2 | ||||||||||||
cash-flows.row.operating-cash-flow | 0 | 1547.2 | 1384.3 | 3639.9 | ||||||||||||
cash-flows.row.capital-expenditure | 0 | -7237.5 | -243.2 | -294.9 | ||||||||||||
cash-flows.row.free-cash-flow | 0 | -5690.3 | 1141.1 | 3345 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 9417 | 9433.4 | 10402.4 | ||||||||||||
income-statement-row.row.cost-of-revenue | 0 | 3028.2 | 2797 | 2597 | ||||||||||||
income-statement-row.row.gross-profit | 0 | 6388.8 | 6636.4 | 7805.4 | ||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.research-development | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.operating-expenses | 0 | 4757.5 | 4362.3 | 4940.2 | ||||||||||||
income-statement-row.row.cost-and-expenses | 0 | 7785.7 | 7159.3 | 7537.2 | ||||||||||||
income-statement-row.row.interest-income | 0 | 276.5 | 89.3 | 11 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 268.6 | 263.7 | 289.9 | ||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | ||||||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -334.5 | 1317.7 | -1120 | ||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.other-operating-expenses | 0 | 0 | 0 | 0 | ||||||||||||
income-statement-row.row.total-operating-expenses | 0 | -334.5 | 1317.7 | -1120 | ||||||||||||
income-statement-row.row.interest-expense | 0 | 268.6 | 263.7 | 289.9 | ||||||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 494.8 | 518.7 | 487.3 | ||||||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | ||||||||||||
income-statement-row.row.operating-income | 0 | 1631.3 | 2274.1 | 2865.2 | ||||||||||||
income-statement-row.row.income-before-tax | 0 | 1296.8 | 3591.8 | 1745.2 | ||||||||||||
income-statement-row.row.income-tax-expense | 0 | 135.3 | 632.8 | 52.5 | ||||||||||||
income-statement-row.row.net-income | 0 | 1161.1 | 3046.9 | 1556.1 |
Dažnai užduodami klausimai
Kas yra Biogen Inc (0R1B.L) bendras turtas?
Biogen Inc (0R1B.L) bendras turtas yra 26844800000.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra N/A.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.678.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra -39.271.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.123.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.173.
Kas yra Biogen Inc (0R1B.L) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 1161100000.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 7428500000.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 4757500000.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 0.000.